EU Revised Legislation Provides One-Year Exclusivity For OTC Switches
This article was originally published in The Tan Sheet
Executive Summary
Rx-to-OTC switches in the European Union will be provided one year of data exclusivity, instead of the previously proposed three-year period, in a proposed amendment to EU pharmaceutical legislation recently approved by the European Parliament